Evidence map›Paper›PMID 41258598›Full record

ArticleDiscover oncology2025

A rare primary adult-type fibrosarcoma of tibia.

Yueming Mu, Yinping Jiang, Xudong Zhu, Shenglong Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yueming Mu *Department of Orthopaedics, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, 010030, Inner Mongolia, China.
Yinping JiangMarkey Cancer Center, University of Kentucky, Lexington, KY, 40536, USA.
Xudong Zhu *Department of Hepatopancreatobiliary Surgery, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, 110042, Liaoning, China. xdzhu@cmu.edu.cn.
Shenglong LiSecond Ward of Bone and Soft Tissue Tumor Surgery, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, 110042, Liaoning, China. lishenglong@cancerhosp-ln-cmu.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrimary adult-type fibrosarcoma of bone is extremely rare and has been infrequently reported in the literature. To the best of our knowledge, there are no previous reports of its occurrence in the tibia of a teenager. CASE PRESENTATION: Here, we report the case of a 14-year-old girl diagnosed with bone fibrosarcoma of the tibia without distant metastasis. After local focus resection, iliac bone transplantation, and filling, there were no signs of tumor recurrence or metastasis. The patient returned to normal walking 4 weeks after surgery.

conclusionsThis case report may assist clinicians in the diagnosis and management of primary fibrosarcoma of the bone in teenagers, particularly given that our patient remains recurrence-free.

Indexed as

Bone destructionBone fibrosarcomaTeenager

Identifiers

PMID41258598
PMCPMC12748485

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.